NCT06772675 Vancomycin Reduction Practices (VRP) in the NICU
| NCT ID | NCT06772675 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Antibiotic Stewardship |
| Study Type | INTERVENTIONAL |
| Enrollment | 13 participants |
| Start Date | 2025-06-02 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 13 participants in total. It began in 2025-06-02 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.
Eligibility Criteria
Inclusion Criteria: * Level III NICU * Affiliated with Kaiser Permanente Northern California (KPNC) or Children's Hospital of Philadelphia Newborn Care Network (CNBCN) * Recruited by study team Exclusion Criteria: * Site not recruited for the study
Contact & Investigator
Sagori Mukhopadhyay, MD, MMSc
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT06772675 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Antibiotic Stewardship. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06772675 currently recruiting?
Yes, NCT06772675 is actively recruiting participants. Contact the research team at kayla.gilpin@pennmedicine.upenn.edu for enrollment information.
Where is the NCT06772675 trial being conducted?
This trial is being conducted at Modesto, United States, Oakland, United States, Roseville, United States, San Francisco, United States and 9 additional locations.
Who is sponsoring the NCT06772675 clinical trial?
NCT06772675 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Sagori Mukhopadhyay, MD, MMSc at Children's Hospital of Philadelphia. The trial plans to enroll 13 participants.